We-P11:136 Metabolic syndrome (MS) in early phase of essential hypertension (EH)

Jelaković, Bojan; Laganović, Mario; Pećin, Ivan; Boršo, Gordana; Kuzmanić, Duško; Vrkić, Tajana Željković; Dika, Živka

doi:10.1016/s1567-5688(06)81490-x

Cited by 3 publications

(7 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In a study conducted in 2003, based on the Croatian Adult Health Survey (CAHS), arterial hypertension prevalence was 40.5% in men and 34.9% in women (6). The EH-UH study (7) conducted in 2005 found the prevalence of arterial hypertension to be 35.5% in men and 39.7% in women.…”

Section: Discussionmentioning

confidence: 99%

Undiagnosed hypertension in Croatia

Uhernik¹,

Kralj²,

Čukelj³

et al. 2023

Croat Med J

View full text Add to dashboard Cite

Aim To determine the prevalence of undiagnosed hypertension in Croatia, and to assess its association with various demographic, socioeconomic, lifestyle, and health care usage factors. Methods We used the data from European Health Interview Survey wave 3, conducted in Croatia in 2019. The representative sample consisted of 5461 individuals aged 15 years and older. The association of undiagnosed hypertension with various factors was assessed with simple and multiple logistic regression models. The factors that contribute to undiagnosed hypertension were identified by comparing undiagnosed hypertension with normotension in the first model and with diagnosed hypertension in the second model. Results In the multiple logistic regression model, women and older age groups had lower adjusted odds ratio (OR) for undiagnosed hypertension than men and the youngest age group. Respondents living in the Adriatic region had a higher adjusted OR for undiagnosed hypertension than those living in the Continental region. Respondents who did not consult their family doctor in the previous 12 months and those who did not have their blood pressure measured by a health professional in the previous 12 months had a higher adjusted OR for undiagnosed hypertension. Conclusion Undiagnosed hypertension was significantly associated with male sex, age from 35 to 74, overweight, lack of consultation with a family doctor, and living in the Adriatic region. The results of this study should be used to inform preventive public health measures and activities.

show abstract

Section: Discussionmentioning

confidence: 99%

Undiagnosed hypertension in Croatia

Uhernik¹,

Kralj²,

Čukelj³

et al. 2023

Croat Med J

View full text Add to dashboard Cite

show abstract

“…Questionnaire was made after series of consultations with experts and literature and it was compiled by model of large clinical trials conducted in Europe and Croatia [INTERHEART 9 , EUROASPIRE (European action on secondary prevention by intervention to reduce events) I 22 and II 23 , EH--UH (Epidemiology of hypertension in Croatia) 24 , TAS-PIC-CRO V (Treatment and secondary prevention of ischemic coronary events in Croatia) 25 ]. This allowed the investigators to be able to efficiently compare results.…”

Section: Methodsmentioning

confidence: 99%

The Prevalence of Hypertension among Croatian Hospitalized Coronary Heart Disease Patients

Vražić

Šikić²,

Lucijanić³

et al. 2012

Coll Antropol

View full text Add to dashboard Cite

show abstract

“…Jedan je od najvećih javnozdravstvenih problema (64 milijuna DALY -disability adjusted life years; 4,4%) 1 . Osim za KV i CV bolesti, AH je čimbenik rizika i razvoja kroničnih bubrežnih bolesti 2 .…”

Section: Uvodunclassified

“…Prema studiji EH-UH, prevalencija hipertenzije u Hrvatskoj je 37,5%. Pedeset devet posto hipertoničara uzima antihipertenzivnu terapiju, a samo 19,4 % njih ima dobru kontrolu arterijskog tlaka 1 . Američko kardiološko društvo predvidjelo je da će do 2030. godine godišnji ekonomski trošak zbog KV bolesti uvjetovanih hipertenzijom porasti na oko 200 milijardi američkih dolara 3, 4 .…”

Section: Uvodunclassified

“…Time se pointroduction Arterial hypertension (AH) is the most important changeable risk factor for cardiovascular (CV) and cerebrovascular (CBV) morbidity and mortality. It is one of the most significant public health problems (64 million disability adjusted life years (DALY); 4.4%) 1 . In addition to CV and CBV diseases, AH is also a risk factor for the development of chronic kidney diseases 2 .…”

Section: Važnost Kontrole Arterijskoga Tlakamentioning

confidence: 99%

See 1 more Smart Citation

What does fixed-dose triple-combination treatment for arterial hypertension bring us?

Frančula-Zaninović¹

2018

Cardiologia Croatica

View full text Add to dashboard Cite

Sažetak: Prevalencija arterijske hipertenzije (AH) i dalje je visoka. AH je najvažniji promjenjivi kardiovaskularni (KV) čimbenik rizika te je znatno povezana s visokim morbiditetom i mortalitetom od KV i cerebrovaskularnih (CV) bolesti. Stoga je AH velik javnozdravstveni problem. Ona je multifaktorijalna te je pristup njezinu liječenju zasnovan na kombiniranoj terapiji. Kombinirana se terapija sastoji od dvaju ili više antihipertenziva različitih skupina, različita mehanizma djelovanja, čime se brže postižu ciljne vrijednosti arterijskoga tlaka (AT). Prema smjernicama za liječenje arterijske hipertenzije koje su izdali Europsko društvo za hipertenziju (ESH) i Europsko kardiološko društvo (ESC), preporuka je da se kombinirana terapija može uvesti već u 1. stupnju bolesti, kao prva crta liječenja u slučaju visokog KV rizika i komorbiditeta, ili u slučaju neuspješnog liječenja jednim lijekom. Nažalost, uzimanjem više tableta tijekom dana smanjuje se adherentnost u liječenju. Svrha je suvremenog liječenja AH-a da se fiksnim kombinacijama antihipertenziva komplementarnog i sinergističkog djelovanja, postigne što učinkovitije liječenje AH-a. Arterijski tlak se mnogo bolje kontrolira već manjim dozama djelotvornih komponenti u kombinaciji, a time se smanjuje i incidencija nuspojava. Uzimanjem terapije jednom na dan, koja je djelotvorna i ne opterećuje bolesnika, znatno se povećava adherentnost u liječenju. Krajnji cilj ovakvoga uspješnog liječenja AH-a jest smanjenje morbiditeta i mortaliteta od KV i CV bolesti. Prema smjernicama ESH/ESC-a za liječenje hipertenzije, optimalna je kombinacija antihipertenziva triju skupina: inhibitori renin-angitenzin-aldosteronskog sustava, antagonisti kalcijevih kanala i diuretici. SUMMaRY:The prevalence of arterial hypertension (AH) is still high. Hypertension is the most important changeable cardiovascular (CV) risk factor and is significantly associated with high morbidity and mortality from cardiovascular and cerebrovascular (CBV) diseases. AH thus represents a significant healthcare problem. It is multifactorial, and the treatment approach is based on combination treatment. Combination treatment consist of two or more antihypertensives of different groups with different mechanisms, which results in faster achievement of target blood pressure (BP) values. According to the guidelines for the treatment of arterial hypertension published by the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC), it is recommended to introduce the combination therapy already in the first stage of the disease as the first line of treatment in case of high CV risk and comorbidity or in case of failed treatment with a single medication. Unfortunately, prescribing multiple tablets to be taken during the day reduces treatment adherence. The goal of modern AH treatment is to use fixed-dose combinations of antihypertensives with complementary and synergistic effects in order to achieve the most effective treatment. Management of BP is significantly improved even at smaller do...

show abstract

We-P11:136 Metabolic syndrome (MS) in early phase of essential hypertension (EH)

Cited by 3 publications

References 0 publications

Undiagnosed hypertension in Croatia

Undiagnosed hypertension in Croatia

The Prevalence of Hypertension among Croatian Hospitalized Coronary Heart Disease Patients

What does fixed-dose triple-combination treatment for arterial hypertension bring us?

Contact Info

Product

Resources

About